Gen X Adults Are Drinking More Than Any Other Age Group, Surprising New Study Finds - Prevention
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
New research suggests Americans are drinking less than they did during the pandemic—with one major caveat: Adults aged 50-64 are drinking more. Experts have several theories about what may be fueling this trend, from marketing and cultural differences to economic factors. Older adults face different health risks when drinking than young people do. Among the many, many downstream effects of the COVID-19 pandemic was a rise in alcohol use—a trend that continued into 2022. Fortunately, recent data suggest Americans are drinking less than they did during those years; in 2025, Gallup reported that self-reported drinking has fallen to the lowest levels in its 90 years of tracking. While the overall picture is promising, new research has found a troubling spot: Adults within the Gen X age group are actually drinking more. The study, published in Annals of Internal Medicine, analyzed survey data from more than 114,000 adults gathered by the U. S. Centers for Disease Control (CDC) between 2018 and 2024.
This article is an excerpt. To read the full content, visit the original source. Prevention
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!